review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Yun-Lun Li | Q88337221 |
Honglin Yin | Q93198161 | ||
Xinrong Zhang | Q93198165 | ||
P2093 | author name string | Yang Liu | |
Chao Li | |||
P2860 | cites work | Association of severity of COPD with IgE and interleukin-1beta | Q85201056 |
Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals | Q88681294 | ||
Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE-/- mice | Q90097498 | ||
MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition | Q90123478 | ||
Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target | Q90849396 | ||
MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis | Q91010140 | ||
ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis | Q91112980 | ||
Rosmarinic acid inhibits nicotine-induced C-reactive protein generation by inhibiting NLRP3 inflammasome activation in smooth muscle cells | Q91147635 | ||
The mechanisms of traditional Chinese medicine underlying the prevention and treatment of atherosclerosis | Q91523850 | ||
The role of mitochondria in NLRP3 inflammasome activation | Q91690807 | ||
Dietary Apigenin Reduces Induction of LOX-1 and NLRP3 Expression, Leukocyte Adhesion, and Acetylated Low-Density Lipoprotein Uptake in Human Endothelial Cells Exposed to Trimethylamine-N-Oxide | Q91799822 | ||
Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease | Q91971286 | ||
Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway | Q92063934 | ||
MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice | Q92180952 | ||
Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A | Q92240388 | ||
NLRP3 Inflammasome in Acute Myocardial Infarction | Q92251461 | ||
The NLRP3 inflammasome: a new player in neurological diseases | Q92358046 | ||
Nucleolin promotes Ang II-induced phenotypic transformation of vascular smooth muscle cells by regulating EGF and PDGF-BB | Q92361960 | ||
Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome | Q92691109 | ||
Decreased M1 macrophage polarization in dabigatran-treated Ldlr-deficient mice: Implications for atherosclerosis and adipose tissue inflammation | Q92987254 | ||
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. | Q50594261 | ||
Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. | Q51366437 | ||
Cereal Fiber Ameliorates High Fat/Cholesterol Diet-Induced Atherosclerosis by modulating NLRP3-Inflammasome Pathway in ApoE-/- Mice. | Q52718830 | ||
Berberine Attenuates NLRP3 Inflammasome Activation in Macrophages to Reduce the Secretion of Interleukin-1β. | Q52739107 | ||
Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. | Q52872316 | ||
Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis. | Q53346950 | ||
Inhibitory effects of colchicine on inflammasomes. | Q54258392 | ||
Cardiolipin and the Nlrp3 inflammasome. | Q54635661 | ||
Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy. | Q55248758 | ||
Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis. | Q55266333 | ||
NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout | Q56797722 | ||
Generation of Vascular Endothelial Cells and Hematopoietic Cells by Blastocyst Complementation | Q57292623 | ||
Inflammation in atherosclerosis | Q57295305 | ||
Cathepsin B-Mediated NLRP3 Inflammasome Formation and Activation in Angiotensin II -Induced Hypertensive Mice: Role of Macrophage Digestion Dysfunction | Q57785008 | ||
Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice | Q57967556 | ||
Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition | Q58764473 | ||
P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis. | Q64903655 | ||
Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome | Q81925149 | ||
TRPM2 links oxidative stress to NLRP3 inflammasome activation | Q24600251 | ||
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization | Q24631966 | ||
ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury | Q26748988 | ||
NOD-Like Receptors in Infection, Immunity, and Diseases | Q26775253 | ||
Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
Reactive oxygen species at the crossroads of inflammasome and inflammation | Q26830685 | ||
Gout-associated uric acid crystals activate the NALP3 inflammasome | Q28131797 | ||
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications | Q28253399 | ||
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation | Q28506984 | ||
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome | Q29547419 | ||
Thioredoxin-interacting protein links oxidative stress to inflammasome activation | Q29614471 | ||
Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression | Q29615589 | ||
The NALP3 inflammasome is involved in the innate immune response to amyloid-beta | Q29615595 | ||
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration | Q29615596 | ||
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis | Q29619852 | ||
K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter | Q29620146 | ||
Vascular Smooth Muscle Cells in Atherosclerosis | Q30277316 | ||
Sodium overload and water influx activate the NALP3 inflammasome | Q30497777 | ||
RNA and β-hemolysin of group B Streptococcus induce interleukin-1β (IL-1β) by activating NLRP3 inflammasomes in mouse macrophages. | Q33619299 | ||
Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation | Q33644572 | ||
Macrophage death and defective inflammation resolution in atherosclerosis | Q33789327 | ||
The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation | Q34552775 | ||
CXCL16/SR-PSOX--a friend or a foe in atherosclerosis? | Q34655621 | ||
The macrophage foam cell as a target for therapeutic intervention | Q34986351 | ||
Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome | Q35091448 | ||
Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway | Q35224401 | ||
Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer | Q35815863 | ||
The Importance of NLRP3 Inflammasome in Heart Failure | Q35891957 | ||
Critical role for calcium mobilization in activation of the NLRP3 inflammasome | Q36094313 | ||
Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion | Q36497205 | ||
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis | Q36602763 | ||
ER stress: Autophagy induction, inhibition and selection. | Q36777229 | ||
The role of junctional adhesion molecules in vascular inflammation | Q36831671 | ||
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis | Q36956703 | ||
Monocyte-endothelial cell interactions in the development of atherosclerosis | Q37116502 | ||
Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. | Q37233061 | ||
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility | Q37310504 | ||
Curcumin Represses NLRP3 Inflammasome Activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-Induced Macrophages | Q37323341 | ||
Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner | Q37415517 | ||
The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE-/- Mice | Q37571861 | ||
The NLRP3 inflammasome: a sensor for metabolic danger? | Q37675505 | ||
Lysosomes integrate metabolic-inflammatory cross-talk in primary macrophage inflammasome activation | Q37691689 | ||
The role of the NLRP3 inflammasome in the pathogenesis of airway disease | Q37855212 | ||
Endoplasmic-reticulum calcium depletion and disease | Q37858336 | ||
NLRP3 inflammasome as a novel player in myocardial infarction | Q38196288 | ||
Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice | Q38708257 | ||
POP1 might be recruiting its type-Ia interface for NLRP3-mediated PYD-PYD interaction: Insights from MD simulation. | Q38735950 | ||
Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes | Q38755032 | ||
Why Calcium? How Calcium Became the Best Communicator | Q38909800 | ||
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase | Q38952745 | ||
Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation | Q39109101 | ||
NLRP3 inflammasome: Its regulation and involvement in atherosclerosis | Q39202038 | ||
Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice | Q39602004 | ||
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux | Q39607181 | ||
Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. | Q40568370 | ||
Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice | Q41009240 | ||
Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice | Q41147790 | ||
Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients | Q41468695 | ||
Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation | Q41888241 | ||
Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity | Q42606557 | ||
The Synthetic Lignan Secoisolariciresinol Diglucoside Prevents Asbestos-Induced NLRP3 Inflammasome Activation in Murine Macrophages | Q42725585 | ||
Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy. | Q42771466 | ||
Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification | Q43463230 | ||
NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis | Q43612729 | ||
Boron-Based Inhibitors of the NLRP3 Inflammasome | Q46106516 | ||
Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells | Q46250426 | ||
Response to Letter Regarding Article, "Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet". | Q46716701 | ||
Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxin-interacting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells | Q46799642 | ||
Procyanidin B2 inhibits NLRP3 inflammasome activation in human vascular endothelial cells | Q46806640 | ||
Inhibition of the NLRP3 inflammasome attenuates foam cell formation of THP-1 macrophages by suppressing ox-LDL uptake and promoting cholesterol efflux | Q47419772 | ||
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond | Q47599422 | ||
Monocyte-Macrophages and T Cells in Atherosclerosis | Q47632654 | ||
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases | Q47682969 | ||
Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis | Q48200760 | ||
The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation | Q49906585 | ||
Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. | Q50130043 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 1561342 | |
P577 | publication date | 2020-03-31 | |
P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
P1476 | title | NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis | |
P478 | volume | 2020 |